2018 Executive Sponsors

Executive Insight

2018 Associate Sponsors


2018 Supporting Sponsors

Transparency Life Sciences

2018 Supporting Partners

Patient Worthy

2018 Media Partners

BioPharma Dive
Gene Therapy Net
Pharmaceutical Executive
Technology Networks

Day One

Chair’s Opening Remarks

Anton (Tony) Hoos, MD, PhD, MBA, Head of Medical, Amgen Europe


How to Get the Patient More Involved in Medicines Development: A Multi-stakeholder Point of View on What Good Patient Involvement Looks Like

Anton (Tony) Hoos, MD, PhD, MBA, Head of Medical, Amgen Europe

Sarah DeeleyClinical Country Lead UK & Ireland, Global Clinical Operations, Biogen Idec

David Haerry, Patient Advocate, European AIDS Treatment Group (EATG)

Bettina Ryll, PhD, FounderMelanoma Patient Network Europe


How to Make Patient Involvement Systemic and Sustainable Throughout Medicines Development

Bettina Ryll, PhD, FounderMelanoma Patient Network Europe

Nicola Bedlington, Secretary GeneralEuropean Patients Forum

Nicholas Brooke, Chief Executive OfficerPatient Focused Medicines Development (PFMD)

Irmi Gallmeier, Senior International Health Policy Leader, Patient RelationsF. Hoffman La Roche


CISCRP’s Global Assessment of Patient Perceptions of Clinical Research – A Stakeholders Call to Action

Annick Anderson, MBADirector, Research ServiceCISCRP


Patient Engagement and Partnering Along the Medicine Life Cycle Continuum at UCB

Alexandra Moutet, MDGlobal Head of Patient AffairsUCB


How to Implement Patient Opinion Leader Advisory Boards in the Drug Development Continuum

Jennifer KellyVPHealthiVibe LLC


Case Study: The Impact of a Patient Advisory Board at Santhera Pharmaceuticals

Vanessa dos Reis Ferreira, PhD, MBA, Head of Patient Advocacy EuropeSanthera Pharmaceuticals


Patient Involvement in Medicines Development: How Partnering with Medical Research Charities is Key

Claire Nolan, Research Involvement ManagerParkinson’s UK

Chris Macdonald, Research Involvement ManagerArthritis Research UK


Patient Involvement: Is Pharma Satisfying the Demand?

David Ewbank, PartnerExecutive Insight Healthcare Consultants

Meike Wenzel, PartnerExecutive Insight Healthcare Consultants


Tackling the Legal Barriers of Patient Involvement with Co-Designed Contracts and Agreements: a PFMD, MPE and WECAN Collaboration

Nicholas Brooke, Chief Executive OfficerPatient Focused Medicines Development (PFMD)


The Impact of Young Research Ambassadors on Medicines Development

Jenny Preston, PhD, Patient and Public Involvement Priority LeadNIHR


Patient Point of View on the Progress of Patient Involvement

Alastair Kent, AmbassadorGenetic Alliance UK

Mathieu Boudes, PhD, Project Development & Strategic Alliances Senior ManagerEURODIS

David Haerry, Patient AdvocateEuropean AIDS Treatment Group (EATG)


Day Two

What Does a Truly Patient-Centered Healthcare System Look Like in 5-10 Years?

Alastair Kent, AmbassadorGenetic Alliance UK


A Metrics Case Study: How BMS Measured the Impact of Patient Engagement Clinical Trial Recruitment

Pinal Patel, Strategic Recruitment LeadBristol-Myers Squibb


An Update from EMA on their 1st Public Hearing with Patients, Care Givers, Healthcare Professionals and Academia on Risk Assessment

Nathalie Bere, MSc, Patient Relations CoordinatorEuropean Medicines Agency (EMA)


Patient Views on Mobile Technology in Clinical Trials: Clinical Trials Transformation Initiative’s Stakeholder Perceptions Project

Cindy Geoghegan, Patient Advocate and Cancer Survivor


Empowering the Public to Sign Up for Clinical Research – the UK Clinical Trials Gateway

Clare Shaw, PhD, Join Dementia Research Delivery ManagerNIHR